THE EFFECTIVENESS OF ZINC AND RISEDRONATE ON BONE TURNOVER IN RAT MODEL OF OSTEOPOROSIS ASSESSED WITH THE EXPRESSION OF β-CROSSLAPS
Background: Osteoporosis prevalence in Indonesia is high. Risedronate commonly used for treating the osteoporosis. Unfortunately, long term therapy can cause hazardous adverse effect to the patient. Previous research in rat model osteoporosis, Zinc have a potential effect to prevent and rebuild bone...
Saved in:
Main Authors: | Adam Fajar, Mohammad Rizal Chaidir, Dicky Mulyadi, Ahmad Ramdan, Yoyos Dias Ismiarto |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Airlangga
2019-12-01
|
Series: | Journal Orthopaedi and Traumatology Surabaya |
Subjects: | |
Online Access: | https://e-journal.unair.ac.id/JOINTS/article/view/16567 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Re-Fracture as Impact of Rigid Implant and Bone Osteoporosis: A Case Report
by: Huda Fajar Arianto, et al.
Published: (2022-04-01) -
Prevent Osteoporosis: Catch the Silent Thief
by: Linda B. Bobroff
Published: (2017-05-01) -
Annual Zoledronic Acid for the Treatment of Osteoporosis: A Randomized Controlled Trial
by: Asif Hussain, et al.
Published: (2023-01-01) -
Jingui Shenqi Wan alleviates bone loss induced by primary osteoporosis by inhibiting osteoblast pyroptosis
by: Yuwangxuan Qian, et al.
Published: (2025-02-01) -
Efficacy and safety of sequential therapy for primary osteoporosis with bone formation promoters followed by bone resorption inhibitors: a meta-analysis
by: Yuxin Liu, et al.
Published: (2025-02-01)